InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (5 ops.)
Browse the full record of transactions filed by Flynn James E, Director. Director active across 10 companies, notably Werewolf Therapeutics, Inc.. In total, 24 disclosures have been recorded. Total volume traded: €15.9m. The latest transaction was disclosed on 6 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations24 total
€310,63113,132 shares@ €23.65450.0076% mcap9.5% of flow
Common Stock
SEC:0001193805-22-000932:0·
40 shares
Class A Common Stock
SEC:0001193805-21-001590·
40 shares
Class A Common Stock
SEC:0001193805-21-001590:0·
756,472 shares
Common Stock
SEC:0001193805-21-001508·
756,472 shares
Common Stock
SEC:0001193805-21-001508:0·
01,800 shares0
Common Stock
SEC:0001193805-21-001271·
01,800 shares0
Common Stock
SEC:0001193805-21-001271:0·
8,494,140 shares
Class A Common Stock
SEC:0001193805-21-001101·
8,494,140 shares
Class A Common Stock
SEC:0001193805-21-001101:0·
€5m390,836 shares@ €11.8706100.0% of flow
Common Stock
SEC:0001193805-21-001059·
Ideal exit: 15 Apr 2022 (T+270)
€5m390,836 shares@ €11.870650.0% of flow
Common Stock
SEC:0001193805-21-001059:0·
Ideal exit: 15 Apr 2022 (T+270)
€1m99,325 shares@ €13.3440.032% mcap89.7% of flow
Common Stock
SEC:0001193805-21-001014·
€1m99,325 shares@ €13.3440.032% mcap40.6% of flow
Common Stock
SEC:0001193805-21-001014:0·
€152,20010,599 shares@ €14.35980.0037% mcap10.3% of flow
Common Stock
SEC:0001193805-21-000999·
€152,20010,599 shares@ €14.35980.0037% mcap4.7% of flow
Common Stock
SEC:0001193805-21-000999:0·
€2m228,569 shares@ €7.3797100.0% of flow
Common Stock
SEC:0001193805-21-000974·
Ideal exit: 27 Mar 2022 (T+270)
€2m228,569 shares@ €7.37970.53% mcap50.0% of flow
Common Stock
SEC:0001193805-21-000974:0·
Ideal exit: 27 Mar 2022 (T+270)
€79m9,600,000 shares@ €8.215100.0% of flow
Class A common stock
SEC:0001193805-21-000842·
€79m9,600,000 shares@ €8.21550.0% of flow
Class A common stock
SEC:0001193805-21-000842:0·
6,457,723 shares
Common Stock
SEC:0001193805-21-000800·
6,457,723 shares
Common Stock
SEC:0001193805-21-000800:0·
1,752,787 shares
Common Stock
SEC:0001193805-21-000599·
1,752,787 shares
Common Stock
SEC:0001193805-21-000599:0·
24 of 24 declarations
About Flynn James E
James E Flynn is an executive at Werewolf Therapeutics, Inc.
